SEC Form 4 · accession 0001019687-15-001246
Medytox Solutions, Inc. · MMMS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Seamus Lagan
Officer — Chief Executive Officer · Director · 10% Owner
Alcimede LLC
Other
Period of report
Feb 5, 2013
Accepted (ET)
Apr 1, 2015 · 10:39 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374536
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 5, 2013 | G | 4,500,000 | $0.00 | D | 0 | I | By Alcimede LLC |
| Common StockF1 | Feb 5, 2013 | G | 4,500,000 | $0.00 | A | 4,500,000 | I | By Epizon Ltd. |
| Common StockF2 | Feb 8, 2013 | J | 4,500,000 | $0.00 | D | 0 | I | See note |
| Common StockF3 | Dec 31, 2013 | G | 1,300,000 | $0.00 | D | 0 | D | |
| Restricted StockF4 | Mar 13, 2014 | A | 30,000 | $0.00 | A | 30,000 | I | By Alcimede, LLC |
| Series B Non-Convertible Preferred StockF5 | Feb 5, 2013 | G | 1,000 | $0.00 | A | 1,000 | I | By Epizon Ltd. |
| Series B Non-Convertible Preferred StockF5 | Feb 5, 2013 | G | 1,000 | $0.00 | D | 0 | I | By Alcimede, LLC |
| Series B Non-Convertible Preferred StockF2 | Feb 8, 2013 | J | 1,000 | $0.00 | D | 0 | I | See note |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On February 5, 2013, 4,500,000 shares of the Issuer's Common Stock owned of record by Alcimede LLC were distributed to Epizon Ltd. Seamus Lagan was the then sole owner of Epizon Ltd., and disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.
- F2On February 8, 2013, Seamus Lagan distributed all of the capital stock of Epizon Ltd. to The Shanoven Trust. P. Wilhelm F. Toothe is the trustee of The Shanoven Trust. Mr. Lagan is the settlor and Mr. Lagan and his family are the beneficiaries of The Shanoven Trust. As a consequence of the distribution of all of the capital stock of Epizon Ltd. to The Shanoven Trust, Mr. Lagan is no longer a beneficial owner of the Issuer's Common Stock and the Issuer's Series B Non-Convertible Preferred Stock owned of record by Epizon Ltd. pursuant to Section 16(a) of the Securities Exchange Act of 1934.
- F3On December 31, 2013, Seamus Lagan distributed 1,300,000 shares of the Issuer's Common Stock to Epizon Ltd.
- F4The grant of the restricted stock of the Issuer vests in full on September 13, 2014, subject to the continued engagement of Alcimede LLC by the Issuer.
- F5The 1,000 shares of the Issuer's Series B Non-Convertible Preferred Stock owned of record by Alcimede LLC, were distributed to Epizon Ltd. on February 5, 2013. On February 5, 2013, Seamus Lagan was the sole owner of Epizon Ltd., and disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.